IBO vs BIIB: Which Stock is Better?

Side-by-side comparison of Impact Biomedical Inc and Biogen Inc in 2026

Comparison Updated:

IBO

Impact Biomedical Inc

$0.66

BIIB

Biogen Inc

$176.02

Key Metrics Comparison

MetricIBOBIIBWinner
Market Cap$71.50M$25.83BBIIB
P/E RatioN/A20.05BIIB
EPS (TTM)$N/A$8.78BIIB
Revenue Growth0.0%-0.1%BIIB
Gross Margin-1225.0%78.9%BIIB

Analyze IBO

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IBO or BIIB a better investment?

Comparing IBO and BIIB: Impact Biomedical Inc has a market cap of $71.50M while Biogen Inc has $25.83B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IBO and BIIB?

IBO (Impact Biomedical Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IBO or BIIB?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IBO or BIIB?

IBO has higher revenue growth at 0.0% vs -0.1% for BIIB.

Which company is more profitable: IBO or BIIB?

Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -1225.0% for IBO.

Which is the larger company: IBO or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $25.83B compared to $71.50M for IBO.

Should I buy IBO or BIIB in 2026?

Both IBO and BIIB have investment merit. IBO trades at $0.66 while BIIB trades at $176.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IBO and BIIB stock?

Key differences: Market Cap ($71.50M vs $25.83B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.0% vs -0.1%), Gross Margin (-1225.0% vs 78.9%).

Popular Stock Comparisons